Cardiometabolic Health Congress (CMHC) | VuMedi

Cardiometabolic Health Congress (CMHC)

Cardiometabolic Health Congress (CMHC)

The global epidemic of metabolic syndrome, a constellation of cardiometabolic risk factors, and that of obesity, type 2 diabetes, atherosclerosis, chronic kidney disease, cardiovascular disease, and NAFLD/NASH, have become the modern-day health hazard across the world. Lifestyle factors, including a lack of physical activity and proper nutrition, as well as ...
read more ↘ smoking, can further exacerbate the impacts of cardiometabolic risk or disease, which is showing no signs of slowing down. Overall, the numbers are particularly striking. There are more than 463 million adults living with diabetes worldwide, and the number is expected to rise to more than 700 million by 2045.1 Furthermore, 232 million have undiagnosed diabetes with an additional 374 million having prediabetes.1 The increasing prevalence of overweight and obesity (now estimated to affect 2 billion adults, or nearly 30% of the world population), high cholesterol (>40% of the world’s population), and hypertension (>1 billion), together with type 2 diabetes (T2D), are some of the major drivers of morbidity and mortality worldwide.2-4 They affect multiple organ systems, including the heart, liver, and kidneys, spanning several disease domains and outcomes.

Although clinicians are learning more about the interconnections between these conditions and risk factors, the application of these principles to patient care remains in its infancy. As these diseases and risk factors exist in a continuum, they cannot be treated in silos, which is unfortunately what tends to happen in clinical practice. The Cardiometabolic Health Congress (CMHC) has been at the forefront of looking at the whole spectrum of cardiometabolic disease, including obesity, diabetes, lipids, hypertension, cardio-renal disease, and practical ways to address them. Through our live conferences and extensive online education platforms, we strive to synthesize and translate the latest cutting-edge medical research into practical clinical strategies for preventing, delaying, diagnosing, treating, and managing the whole spectrum of cardiometabolic disorders. The goal is to provide the medical community with evidence-based interventions that they can apply immediately in clinical practice to improve health outcomes and quality of life for the growing numbers of patients at increased cardiometabolic risk.
↖ read less

Lipid Management

Cardiometabolic Health Congress (CMHC)

Q&A on Novel Therapies and Approaches in LDL-C Reduction

FEATURING Salim Virani, Christie Ballantyne, Pam Taub

604 views
September 22, 2020

Cardiometabolic Health Congress (CMHC)

55 y/o Female With Hypertension, Hypothyroidism, and Metabolic Syndrome: How to Optimize LDL-C Reduction Therapy?

FEATURING Salim Virani, Christie Ballantyne, Pam Taub

441 views
September 22, 2020
2

Cardiometabolic Health Congress (CMHC)

2020 Update on LDL-C Reduction: Does Aggressive LDL-C Lowering Therapy Eliminates CVD Risk? What Are the Benefits of LDL Lowering on Plaque Regression?

FEATURING Pam Taub

903 views
September 22, 2020
9

Cardiometabolic Health Congress (CMHC)

2020 Update on Statin Therapy in ASCVD: Why Does Residual Risk Occur in Clinical Practice? Can the Big Data Asist in Identifying Patients With SASEs? Why Are System-Level Interventions Needed?

FEATURING Salim Virani

121 views
September 22, 2020

Cardiometabolic Health Congress (CMHC)

2020 Update on Lipid Lowering Therapy in ASCD: What Medications Are Available to Address Residual Risk of in Statin Treated Patients? What Do the Treatment Guidelines Define as High-Risk Patients in Primary Prevention?

FEATURING Salim Virani

895 views
September 22, 2020
3

Cardiometabolic Health Congress (CMHC)

Part 1 - Targeting Inflammation- Updates on Pathophysiology and Clinical Outcomes

FEATURING Peter Libby

97 views
October 22, 2019
1

Cardiometabolic Health Congress (CMHC)

Part 2 - What Have We Learned from the CANTOS Trial and Looking Forward?

96 views
October 22, 2019
1

Cardiometabolic Health Congress (CMHC)

Role of Inflammation in the Pathogenesis of Atherosclerosis and Atherothrombotic Events: Biology and Pathogenesis

18 views
June 17, 2019

Cardiometabolic Health Congress (CMHC)

Interactive Patient Case Discussion - Calculating Cardiovascular Disease Risk

FEATURING Christie Ballantyne

211 views
June 17, 2019
1

Cardiometabolic Health Congress (CMHC)

FH Patient Case: What’s Being Done

FEATURING Catherine Davis

17 views
January 10, 2019

Cardiometabolic Health Congress (CMHC)

Triglycerides and Cardiovascular Disease

FEATURING Robert Eckel, Alan Chait, Sotirios Tsimikas, Karol Watson

432 views
January 10, 2019
3

Cardiometabolic Health Congress (CMHC)

Familial Hypercholesterolemia: Identification and Management

FEATURING Christie Ballantyne, Joshua Knowles

315 views
January 10, 2019
2

Cardiometabolic Health Congress (CMHC)

Importance of Lifestyle Modifications and Incorporation into Clinical Practice for Treatment of CV Disease

FEATURING Robert Eckel

724 views
January 10, 2019
2

Cardiometabolic Health Congress (CMHC)

Non-Statin Drugs and New Approaches

FEATURING Marc Sabatine, Christie Ballantyne

1,026 views
January 10, 2019
6

Cardiometabolic Health Congress (CMHC)

Best Practices: Effective Management of the Authorization Process for PCSK9

FEATURING Pamela Morris

251 views
May 7, 2018
1

Cardiometabolic Health Congress (CMHC)

Strategies and Resources to Support the PCSK9 Authorization Process

FEATURING Kim Birtcher

56 views
May 7, 2018

Cardiometabolic Health Congress (CMHC)

What Challenges Do You Face With the Authorization of PCSK9 Inhibitors for Your Patients

FEATURING Robert Eckel

123 views
May 7, 2018